Investment Professionals

George W. Siguler

Drew Guff

Donald Spencer

Kenneth Burns

Maria Boyazny

Patricia Dinneen

Kevin Kester

Ching Tan

Praneet Singh

James Corl

James Gereghty

Solomon Owayda

Michael Romanowski

Avinash Amin

Anthony Corriggio

Ross Goodhart

David Y. Lee

Jonathan Wilson

Jason Mundt

Marianna Fassinotti

Nestor Weigand

Angela Yang

Randall Beeler

Aviral Jain

Erol Sarikaya

Matthew Miller

Michael Yang

Sara Sherman

Anthony Cusano

Thomas McGowan

Clifford Yonce

Michael P. Keough

Sloane Schuster

Leslie Tanca

Megan McHale

Lindsey Cooper

David Dubinsky

Michael Calandra

Suzanne Murray

Daniel Rochkind

Natalie Geissler

Nina Deis

Jarrad Krulick

Sabina Elizandro

Eunice Grobler

Jun Isoda

Jodee Telfer

Mike Wou

Lisa Yoon

Stacey Lusk

Shandell Johnson

Jonathan Miles

Michael Sharp

Jessie Bai

Nataliya Konovalova

Donald Spencer

Terri Ambron Liftin

Huwaida Hassan

Marcela Cano

Heidi Alleyne

Vladimir Andrienko

Evgeniy Gorkov

Peter Kochevrin

Yuri Mashintsev

Dmitry Piskulov

Oleg Svintsitski

Avinash Amin

Principal

New York Office

Avinash Amin is a Principal at Siguler Guff and joined the Firm in 2009.  Mr. Amin is a member of the Firm’s investment team and is responsible for overseeing fund selection and monitoring the investment portfolios.  Prior to joining Siguler Guff, Mr. Amin was a Senior Vice President and Head of the Private Equity Group at Summit Strategies Group, an institutional investment advisor with over 70 clients and $150 billion in assets advised.  At Summit, he managed private equity portfolios with over $1 billion in annual commitments and $3 billion in net asset value across buyout, venture capital and distressed strategies.  Mr. Amin also managed Summit’s private equity advisory business and was responsible for strategy selection, manager due diligence, fund selection and reporting.

Previously, Mr. Amin was the Chief Clinical Officer at Novactyl, Inc., a venture-backed pharmaceutical company.  At Novactyl, he led the development of the company’s early-stage pharmaceutical products, which involved conducting clinical trials and handling regulatory affairs.  Mr. Amin also managed the firm’s intellectual property portfolio and invented several key patents.  Prior to working at Novactyl, Mr. Amin co-founded TSVI, a global BPO company focused on the health care vertical with offices in the U.S. and India.  He has also done consulting work for a number of health care venture capital firms, performing investment due diligence on their behalf.

Mr. Amin holds a B.A. and an M.D. from Washington University in St. Louis and is Board Certified in Internal Medicine.

 

 
© 2009 Copyright Siguler Guff & Company, LP. All rights reserved. Best viewed with Adobe Flash Disclaimers Powered by